KAMI PETERSON: Open Payments
NPI 1679955629 · DICKINSON, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,027 in 70 payments from 13 companies in 2025. Trend: 2023 $1,011 · 2024 $1,037 · 2025 $1,027
Food & beverage: $1,027
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $172 |
| PFIZER INC. | 15 | $172 |
| Amgen Inc. | 11 | $158 |
| Novartis Pharmaceuticals Corporation | 7 | $122 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $115 |
| Astellas Pharma US Inc | 2 | $48 |
| Neurocrine BioSciences, Inc. | 3 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $47 |
| E.R. Squibb & Sons, L.L.C. | 2 | $41 |
| Verona Pharma, Inc. | 2 | $39 |
Products named: VRAYLAR, NURTEC ODT, LEQVIO, CAPLYTA, EVENITY, OTEZLA, ELIQUIS, Veozah.
Industry payments across ND — which companies pay providers there.
